Detection rate of clinically significant prostate cancer in magnetic resonance imaging and ultrasonography ‐fusion transperineal targeted biopsy for lesions with a prostate imaging reporting and data system version 2 score of 3–5

ConclusionsThe detection rate of clinically significant prostate cancer on magnetic resonance imaging/ultrasound rigid fusion targeted biopsy is very low in patients with prostate imaging reporting and data system category  3; therefore, patients with this classification should not undergo targeted biopsy. Prostate‐specific antigen density, prostate volume, locations of suspected cancer and history of biopsy should be considered to predict the detection rate of clinically significant prostate cancer with prostate i maging reporting and data system categories 4 and 5.
Source: International Journal of Urology - Category: Urology & Nephrology Authors: Tags: Original Article Source Type: research